The relationship between ADHD and obesity: implications for therapy
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Increasing attention is being paid to the relationship between attention deficit/hyperactivity disorder (ADHD) and obesity. While most available research focused on determining the extent of the association between ADHD and obesity, a few studies have examined the clinical implications of diagnosing/treating ADHD in individuals with obesity. Here, we provide a narrative review of studies addressing the impact of ADHD, or its treatment, in individuals with obesity. Reviewed studies suggest that ADHD impedes the successful treatment of obesity in individuals with comorbid ADHD and obesity. Preliminary evidence also suggests that ADHD treatment might significantly increase the effectiveness of weight management strategies. We discuss the limitations of the reviewed studies and provide suggestions for future research in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568
KESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 5×
“Another more recent study [48] extended these results showing that, among patients presenting for bariatric surgery (n = 60, 78.3% females), those with comorbid ADHD (n = 19) had significantly more difficulties in following visits at 12-month follow-up after bariatric surgery than those without estimated comorbid ADHD…”
BackgroundInfluentialTaheri, S., Lin, L., Austin, D., Young, T., & Mignot, E. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010062 · Cited by 2,477 · cited 1×
“Given the association between poor sleep and increased risk for obesity [36,37] as well as the link between ADHD and sleep disorders [38–41], poor sleep should be taken into account as a possible contributing factor in the relationship between ADHD and obesity.”
BackgroundFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822 · cited 1×
“Its estimated worldwide-pooled prevalence is around 5% in school-age children, as found in a 2007 meta-analysis [5] that was recently updated [6].”
BackgroundPliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421 · cited 2×
“2%) screened positive for ADHD diagnosed by an experienced clinician on the basis of the clinical interview, the ASRS [47], the Wender Utah Rating Scale [56] and school reports cards (when available).”
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167
Self-citationEuropean clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682 · cited 1×
“, [11]), at least for severe cases [12,13], or as treatment strategy for patients who have not responded to nonpharmacological interventions [12,13].”
BackgroundEconomic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States
Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., Erder, M. H., & Neumann, P. J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.07.008 · Cited by 440 · cited 5×
“In the first, Cook et al. [49] assessed a nationally representative sample of youth in the USA (n = 45,897, age range: 10–17 years) and found that youth with ADHD participated in fewer activities and organized sport than those without ADHD (n = 29,801) [Odds ratio (OR): 95% CI: 1.57 (1.06–2.34)].”
BackgroundInfluentialCortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336 · cited 1×
“Clearly, a possible important confounder of this study, as well as of those previously mentioned on the effect of ADHD treatment on obesity rates in individuals with comorbid ADHD [51,53,54], is the anorexigenic effect associated with psychostimulant treatment [57].”
BackgroundSelf-citationWaring, M. E., & Lapane, K. L. (2008) · Pediatrics · doi:10.1542/peds.2007-1955 · Cited by 294
Castells, X., Ramos-Quiroga, J. A., Rigau, D., Bosch, R., Nogueira, M., Vidal, X., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11539440-000000000-00000 · Cited by 197 · cited 1×
“, methylphenidate [14–17] or mixed amphetamine salts [18] and other amphetamines [19]) and some nonpsychostimulant treatments, such as atomoxetine [20–23], are significantly more efficacious than placebo, at least in the short term, when considering short-term change in ADHD core symptoms”
BackgroundCheng, J. Y. W., Chen, R. Y. L., Ko, J. S. N., & Ng, E. M. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0840-x · Cited by 185 · cited 1×
“, methylphenidate [14–17] or mixed amphetamine salts [18] and other amphetamines [19]) and some nonpsychostimulant treatments, such as atomoxetine [20–23], are significantly more efficacious than placebo, at least in the short term, when considering short-term change in ADHD core symptoms”
BackgroundFuture Research Directions in Sleep and ADHD: Report of a Consensus Working Group
Owens, J., Gruber, R., Brown, T., Corkum, P., Cortese, S., O’Brien, L., Stein, M., & Weiss, M. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712457992 · Cited by 143
Self-citationKoesters, M., Becker, T., Kilian, R., Fegert, J., & Weinmann, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108092338 · Cited by 142 · cited 1×
“, methylphenidate [14–17] or mixed amphetamine salts [18] and other amphetamines [19]) and some nonpsychostimulant treatments, such as atomoxetine [20–23], are significantly more efficacious than placebo, at least in the short term, when considering short-term change in ADHD core symptoms”
BackgroundCunill, R., Castells, X., Tobias, A., & Capellà, D. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3473 · Cited by 70 · cited 1×
“, methylphenidate [14–17] or mixed amphetamine salts [18] and other amphetamines [19]) and some nonpsychostimulant treatments, such as atomoxetine [20–23], are significantly more efficacious than placebo, at least in the short term, when considering short-term change in ADHD core symptoms”
BackgroundAdult attention-deficit hyperactivity disorder and obesity: epidemiological study
Cortese, S., Faraone, S. V., Bernardi, S., Wang, S., & Blanco, C. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.123299 · Cited by 67 · cited 1×
“As for ADHD, there has been rising interest, in particular, on its possible association with obesity or overweight [26,27].”
BackgroundSelf-citationKratochvil, C. J., Milton, D. R., Vaughan, B. S., & Greenhill, L. L. (2008) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-2-25 · Cited by 64
Lecendreux, M., & Cortese, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1799 · Cited by 58 · cited 1×
“ADHD is often comorbid with other neuropsychiatric conditions, such as oppositional defiant disorder/ conduct disorder, mood and anxiety disorders and sleep disturbances [2,3].”
BackgroundSelf-citationTanaka, Y., Rohde, L. A., Jin, L., Feldman, P. D., & Upadhyaya, H. P. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0049 · Cited by 28
Cited by
Young, S., Adamo, N., Ásgeirsdóttir, B. B., Branney, P., Beckett, M., Colley, W., Cubbin, S., Deeley, Q., Farrag, E., Gudjonsson, G., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02707-9 · Cited by 610
Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis
Cortese, S., Moreira-Maia, C. R., St. Fleur, D., Morcillo-Peñalver, C., Rohde, L. A., & Faraone, S. V. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020266 · Cited by 606
Self-citationAdult attention-deficit hyperactivity disorder: key conceptual issues
Asherson, P., Buitelaar, J., Faraone, S. V., & Rohde, L. A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30032-3 · Cited by 347
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review
Instanes, J. T., Klungsøyr, K., Halmøy, A., Fasmer, O. B., & Haavik, J. (2018) · Journal of Attention Disorders · doi:10.1177/1087054716669589 · Cited by 232
Maternal body mass index before pregnancy as a risk factor for ADHD and autism in children
Andersen, C. H., Thomsen, P. H., Nohr, E. A., & Lemcke, S. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1027-6 · Cited by 113
“It is suggested that impulsivity as a permanent trait could maintain high-calorie intake and cause obesity [48].”
Background
Metadata
- Authors
- Cortese, S., & Castellanos, F. X.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2014-04-04
- Volume
- 14
- Issue
- 5
- Pages
- 473-479
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2045085299
- Cited by
- 80
- References
- 24
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.